未登录

W

Waqas Ahmed

old dominion university

H指数:8

被引数:184

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cost-Utility of Real-Time Continuous Glucose Monitoring Versus Self-monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Sweden

瑞典胰岛素治疗2型糖尿病患者中，实时连续血糖监测相对于自我血糖监测的成本效用分析

Diabetes Therapy

IF2.6

2025-11-010

OA

A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China

ADVANCES IN THERAPY

IF4

2024-09-181

OAAI

Development of Patient and Caregiver Conceptual Models Investigating the Health-Related Quality of Life Impacts of Malignant Pleural Mesothelioma

PATIENT-PATIENT CENTERED OUTCOMES RESEARCH

IF3.1

2024-04-150

PRE

A time trade-off study to determine health-state utilities of transplant recipients with refractory cytomegalovirus infection with or without resistance

一项时间权衡研究，以确定具有或不具有耐药性的难治性巨细胞病毒感染的移植受者的健康状况

HEALTH AND QUALITY OF LIFE OUTCOMES

IF3.4

2024-03-063

OAAI

The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review

DIABETES TECHNOLOGY & THERAPEUTICS

IF6.3

2024-03-014

PRE

Health-related quality of life in mild-to-moderate COVID-19 in the UK: a cross-sectional study from pre- to post-infection

英国轻中度新型冠状病毒肺炎的健康相关生活质量: 从感染前到感染后的横断面研究

HEALTH AND QUALITY OF LIFE OUTCOMES

IF3.4

2024-01-305

OAAI

Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO2 emissions in Sweden

SCIENTIFIC REPORTS

IF3.9

2024-01-181

OAAI

SARS-CoV-2 and Brain Health: New Challenges in the Era of the Pandemic

IF4.2

2023-10-082

OAAI

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark

在丹麦接受每日多次胰岛素注射的1型糖尿病患者中，实时连续血糖监测与自我血糖监测和间歇性扫描连续血糖监测的成本效用比较

DIABETES OBESITY & METABOLISM

IF5.7

2023-06-196

OA

Tetraspanins as Potential Therapeutic Candidates for Targeting Flaviviruses

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-04-2110

OAAI